Headache is one of the side effects people commonly associate with ketamine, and it does show up in adverse-event lists for ketamine and its nasal-spray cousin esketamine. Yet when researchers compare headache rates in controlled trials, the picture is less straightforward than the reputation suggests. A pooled analysis of randomized esketamine trials found headache was not significantly more frequent in the drug group than in the placebo group, even as dizziness, dissociation, and nausea were clearly elevated. That does not mean ketamine never triggers a headache, but it does mean the link is weaker and more individual than most people assume.
What Controlled Trials Actually Show
The clearest data come from a meta-analysis of randomized controlled trials comparing intranasal esketamine (a close relative of racemic ketamine, approved for treatment-resistant depression) to placebo. When researchers pooled the headache numbers, the relative risk was about 1.28, with a confidence interval that crossed 1.0 and a p-value of 0.19. In plain terms, esketamine users reported headaches somewhat more often than placebo users, but the difference was small enough that it could easily be due to chance. Contrast that with dizziness, which was roughly three times more common in the esketamine group, or dissociation, which was about four and a half times more common. Headache simply was not in the same league as those other side effects.
This matters because many patients approaching ketamine therapy for depression or chronic pain arrive anxious about headaches. It is worth knowing that the side effects you are much more likely to experience are dizziness, a floaty or disconnected feeling, drowsiness, and nausea, all of which tend to fade within an hour or two of treatment.
Why Headaches Still Happen for Some People
Even if the average risk is modest, some people absolutely do get headaches during or after a ketamine session. Several overlapping mechanisms help explain why.
The most immediate is blood pressure. Ketamine stimulates the sympathetic nervous system, leading to short-lived but sometimes sharp spikes in blood pressure and heart rate. Current psychiatric guidelines for intravenous ketamine recommend regular blood pressure monitoring during infusions specifically because of these transient hypertensive episodes. For anyone who is prone to tension-type headaches or migraines triggered by blood pressure swings, even a temporary spike can be enough to set one off.
Separately, ketamine appears to increase blood flow velocity inside the brain through a direct pharmacological effect, not merely as a side effect of rising blood pressure. A study in which researchers used transcranial Doppler ultrasonography found that cerebral blood flow velocity rose significantly after intravenous ketamine, and this increase persisted even when the patients’ blood pressure was held steady with a beta-blocker. In other words, ketamine was dilating blood vessels in the brain on its own. Rapid shifts in cerebral blood flow are a well-known headache trigger in susceptible people, particularly those with a history of migraine.
A third factor involves neurotransmitter activity. Ketamine blocks NMDA receptors, but one downstream consequence of that blockade is a surge in glutamate signaling. Imaging research has demonstrated that ketamine increases glutamate-glutamine cycling in the prefrontal cortex by roughly 13 percent compared to placebo. Glutamate is the brain’s main excitatory chemical messenger, and bursts of glutamate activity have been implicated in migraine pathophysiology for decades. So while the NMDA blockade itself may not directly cause a headache, the resulting glutamate rebound could plausibly tip the balance in people whose brains are already close to a headache threshold.
Dose, Route, and Who Is More Susceptible
Not every ketamine experience carries the same headache risk. A review of common adverse effects of ketamine and esketamine in mood disorder patients noted that the majority of side effects are mild, transient, and dose-dependent, and that they tend to diminish with repeated treatments. That pattern holds for headaches as well: first sessions tend to produce more side effects across the board, and subsequent sessions are often smoother.
Route of administration plays a role too. Intravenous infusions deliver ketamine directly into the bloodstream at a controlled rate, producing predictable blood-level curves. Intranasal esketamine, the FDA-approved form used in clinics for depression, has more variable absorption depending on how well the spray reaches the nasal lining. Intramuscular injections fall somewhere in between. Oral and sublingual forms, used in some at-home protocols, tend to produce lower peak blood levels because much of the drug is broken down during first-pass metabolism in the liver. Lower peak levels generally mean fewer acute side effects, though the trade-off is often less therapeutic potency.
Individual vulnerability matters more than any of these factors. If you already experience frequent tension-type headaches or migraines, your threshold for a headache from any perturbation, whether it is a blood pressure spike, a shift in cerebral blood flow, or a burst of glutamate, is lower. Dehydration on treatment day, poor sleep the night before, caffeine withdrawal, and stress can all narrow the margin further. Clinicians who regularly administer ketamine infusions report that many headache complaints come on days when the patient skipped breakfast or arrived underhydrated.
The Paradox of Ketamine as a Headache Treatment
Here is where the story takes a turn that surprises most people: ketamine is actively studied and used as a treatment for severe, refractory headaches and migraines. A systematic review examined the evidence for ketamine’s efficacy against migraines and other primary headache disorders, comparing it with placebo and other interventions. The interest in using an anesthetic-dose NMDA blocker against headache comes from the idea that resetting overexcited pain circuits, particularly those driven by glutamate signaling gone haywire, can break a headache cycle that has resisted everything else.
In a retrospective study of patients admitted for refractory headache, continuous ketamine infusions at an average maximum rate of about 65 mg per hour led to meaningful relief, and the adverse events during treatment were mild. A separate retrospective study of patients with postdural puncture headache who had not responded to standard treatment found that ketamine infusions were effective in two-thirds of cases. These are not the same population as someone getting a low-dose infusion for depression and experiencing a mild post-treatment headache. The doses, durations, and clinical contexts are very different. But the fact that ketamine can both trigger headaches in some people and relieve them in others underscores that the relationship between this drug and head pain is not a simple cause-and-effect story. It depends on the underlying state of the nervous system, the dose, and the context.
What to Do If You Get a Headache During or After Ketamine
If you develop a headache during a supervised ketamine infusion, the clinical team can usually help in real time. The most common immediate steps include slowing the infusion rate, dimming the lights, and checking your blood pressure. If blood pressure is elevated, the provider may pause the infusion briefly or, in more pronounced cases, administer a short-acting blood-pressure-lowering agent. Most ketamine-related headaches resolve within an hour or two of the infusion ending, especially if hydration is maintained.
For headaches that appear after you leave the clinic, the management is mostly straightforward:
- Hydration: Many post-infusion headaches respond to simply drinking water. Patients are often mildly fasted before treatment, and the combination of fasting, mild dehydration, and the drug’s sympathetic effects can produce a headache that disappears once fluid volume is restored.
- Over-the-counter pain relief: Acetaminophen and ibuprofen are generally safe to take after ketamine unless your provider has told you otherwise. Standard doses are usually sufficient for the mild headaches most people experience.
- Rest in a quiet environment: The dissociative effects of ketamine can make sensory input feel overwhelming for a short window after treatment. Resting in a dim, quiet room often helps the headache resolve faster.
- Caffeine: If you are a regular coffee drinker and skipped your morning cup before the appointment, caffeine withdrawal alone may be the culprit. A small cup of coffee or tea after the session may do more than any painkiller.
For people who find headache is a recurring problem across multiple ketamine sessions, it is worth talking to the prescribing clinician about adjusting the protocol. Options include lowering the dose slightly, slowing the infusion rate, ensuring pre-treatment hydration with intravenous fluids, or pre-medicating with a mild anti-inflammatory. The same review that characterized ketamine’s common side effects noted that severe or bothersome effects may warrant judicious use of adjunctive medications, a principle that applies to recurring headaches as much as to nausea or anxiety.
How Midazolam Pretreatment Changes the Picture
One of the more interesting findings from the cerebral blood flow research is that pretreatment with midazolam, a benzodiazepine, completely prevented the ketamine-induced rise in both cerebral blood flow velocity and mean arterial blood pressure. In the study, the group that received midazolam before ketamine showed no significant cerebrovascular changes, while the group that received ketamine alone had clear increases in both measures. The beta-blocker esmolol, by contrast, held blood pressure steady but did not stop the rise in cerebral blood flow, confirming that the blood-flow increase was a direct brain effect of ketamine rather than a downstream consequence of systemic blood pressure changes.
This has practical implications. Some clinicians already use low-dose benzodiazepines before ketamine infusions to blunt anxiety and dissociation. For patients who consistently develop headaches, adding a small dose of midazolam before the infusion may reduce the cerebrovascular changes that contribute to the headache. The trade-off is that benzodiazepines can also blunt some of ketamine’s antidepressant effect in certain patients, so this is not a universal recommendation. It is a conversation to have with your provider if headaches are a persistent problem and other adjustments have not helped.
When a Headache After Ketamine Deserves Attention
The vast majority of post-ketamine headaches are mild and self-limiting. But a headache that behaves differently from your usual pattern, or that appears with certain other symptoms, warrants a call to your provider or a visit to urgent care.
A sudden, explosive headache, sometimes described as “the worst headache of my life,” is always a red flag regardless of context. If it occurs within hours of ketamine treatment, it should be evaluated promptly. The same goes for a headache accompanied by significant changes in vision, confusion that persists well past the normal dissociative window, stiff neck, or fever. These are not expected effects of ketamine and could indicate something unrelated that happened to coincide with the treatment session.
Persistent headache that worsens when you stand up and improves when you lie down, especially after any procedure involving a spinal needle, suggests a different mechanism entirely: leaking cerebrospinal fluid. This is not a ketamine effect but can occur if the treatment was delivered alongside a spinal or epidural procedure. A positional headache like this typically needs specific treatment, such as an epidural blood patch, rather than standard headache remedies.
For context, elevated blood pressure during ketamine infusion is common and expected. But if you have a history of poorly controlled hypertension, or if your blood pressure remains high long after the infusion has ended, that is worth flagging to your treatment team. Transient blood pressure rises during the session itself are managed as part of normal monitoring, and psychiatric guidelines already recommend an aggressive approach to any hypertensive episodes that occur during intravenous ketamine for depression.
At-Home Ketamine and Headache Risk
The growing availability of at-home ketamine, typically prescribed as sublingual tablets or troches through telehealth services, introduces a wrinkle that in-clinic patients do not face. At home, there is no nurse checking your blood pressure every few minutes, no IV rate to adjust, and no provider on hand if something feels off. The lower bioavailability of oral ketamine means peak blood levels are generally lower, which in principle should mean fewer acute side effects. In practice, though, the lack of monitoring means that mild side effects are more likely to go unaddressed until they become bothersome.
If you are using at-home ketamine and notice headaches after sessions, there are a few things to try before assuming the drug is the problem. First, check your hydration: drink a full glass of water before and after each dose. Second, keep a brief log of what you ate, how much sleep you got, and your caffeine intake on treatment days versus non-treatment days. You may find that the headache correlates more strongly with skipping meals or coffee than with the ketamine itself. Third, try taking the dose in a dim, quiet room and staying reclined for at least 30 minutes afterward rather than returning to screens and activity immediately.
If headaches persist despite these adjustments, your prescribing clinician should know. They can consider reducing the dose, changing the frequency, or switching to a different formulation. The key point is that a headache is not a reason to silently stop treatment or to push through and hope it gets better. It is a signal worth investigating, because more often than not, a simple adjustment resolves it.
Comparing Ketamine’s Headache Profile to Other Psychiatric Medications
It is easy to fixate on ketamine’s side effects because the drug feels exotic and the treatment experience is so different from swallowing a daily pill. But headache is among the most commonly reported side effects of many standard psychiatric medications too. SSRIs, SNRIs, and atypical antipsychotics all list headache as a frequent adverse event in their prescribing information. The crucial difference is that ketamine’s side effects tend to be acute and time-limited: they appear during or shortly after the session and resolve within hours. SSRI headaches, by contrast, can persist for days or weeks during the adjustment period and may recur with dose changes.
The pooled trial data showing that esketamine’s headache rate was not significantly different from placebo puts this in perspective. Placebo groups in depression trials report headaches at surprisingly high rates because headache is common in the general population and even more common in people with depression. Some of the headaches attributed to ketamine in open-label or self-report settings may simply be the baseline headache rate in a population that is already prone to them. That does not mean ketamine never causes a headache, but it does suggest that the drug’s contribution to headache risk, on average, is modest compared to the noise of everyday headache occurrence.